Department of Medical, Surgical and Neurological Sciences, University of Siena, Viale Bracci 16, 53100, Siena, Italy.
Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Institute of Biochemistry, Charité-Universitätsmedizin Berlin, Berlin, Germany.
J Endocrinol Invest. 2020 Dec;43(12):1749-1757. doi: 10.1007/s40618-020-01287-5. Epub 2020 May 20.
In the past, a role of thyroid hormones in human evolution has been hypothesized. T3, the metabolically active form, derives from extrathyroidal conversion of T4 by deionidase 2 (D2) enzyme encoded by DIO2 gene. In thyroid-deficient patients, decreased levels of free T3 have been associated with the polymorphism rs225014 A/G in DIO2, which causes the substitution of Threonine with Alanine (p.Thr92Ala) at protein level.
We compared DNA and protein sequences of D2 from archaic human subspecies with those of contemporary humans.
Neanderthals and Denisovans displayed only the G allele at the rs225014 polymorphism, which encodes for an Alanine on the amino acid level. These data suggest that these hominines were homozygous for the Ala amino acid. These arcaic humans often lived in condition of iodine deficiency and thus, defective mechanisms of T3 biosynthesis could be life threatining. A reduced D2 activity is likely to cause decreased T3 levels, which could be critical for those individuals. Neanderthals and Denisovans were hunters/gatherers, and their diet was mainly based on the consumption of meat, with a low intake of carbohydrates. The need for circulating T3 is reduced at such alimentary conditions. On the basis of our genome comparisons the A allele, corresponding to Threonine and associated with higher levels of circulating T3 in thyroid-deficient patients, appeared for the first time during evolution in Anatomically Modern Humans during the Upper Pleistocene and has been conserved during the Neolithic age. With the advent of agriculture and herding, individuals carrying A allele might have a higher probability for surviving and reproducing. Thus, the variant was positively selected during the evolution.
Here we present an evolutionary perspective for p.Thr92Ala variant of D2 from Neanderthals to Anatomically Modern Humans.
过去,人们假设甲状腺激素在人类进化中发挥了作用。T3 是代谢活跃的形式,由 DIO2 基因编码的脱碘酶 2(D2)酶从甲状腺外转化而来。在甲状腺功能减退的患者中,游离 T3 水平降低与 DIO2 中的 rs225014A/G 多态性有关,该多态性导致蛋白质水平上苏氨酸被丙氨酸取代(p.Thr92Ala)。
我们比较了古人类亚种与现代人类的 D2 的 DNA 和蛋白质序列。
尼安德特人和丹尼索瓦人在 rs225014 多态性中仅显示 G 等位基因,该等位基因在氨基酸水平上编码丙氨酸。这些数据表明这些原始人类是丙氨酸的纯合子。这些古老的人类经常生活在碘缺乏的环境中,因此,T3 生物合成的缺陷机制可能危及生命。D2 活性降低可能导致 T3 水平降低,这对这些个体可能是至关重要的。尼安德特人和丹尼索瓦人是狩猎/采集者,他们的饮食主要以肉类为主,碳水化合物摄入量低。在这种饮食条件下,对循环 T3 的需求减少。根据我们的基因组比较,A 等位基因,对应于苏氨酸,与甲状腺功能减退患者中循环 T3 水平升高有关,在更新世晚期的解剖学现代人类中首次出现,并在新石器时代得到了保留。随着农业和畜牧业的出现,携带 A 等位基因的个体可能有更高的生存和繁殖的可能性。因此,该变体在进化过程中被正向选择。
在这里,我们从尼安德特人到解剖学现代人类提出了 D2 中 p.Thr92Ala 变体的进化视角。